Helicobacter pylori infection is associated with type 2 diabetes among a middle- and old-age Chinese population

Diabetes/Metabolism Research and Reviews

Volumn 32, Issue 1, 2016, Pages 95-101

  Han, Xu ^a   Li, Yaru ^a   Wang, Jing ^a   Liu, Bing ^a   Hu, Hua ^a   Li, Xiulou ^b   Yang, Kun ^b   Yuan, Jing ^a   Yao, Ping ^a   Wei, Sheng ^a   Wang, Youjie ^a   Liang, Yuan ^a   Miao, Xiaoping ^a   Zhang, Xiaomin ^a   Guo, Huan ^a   Yang, Handong ^b   Wu, Tangchun ^a   He, Meian ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Helicobacter pylori; Interaction; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; CARBON; UREA;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHINESE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; POPULATION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; UREA BREATH TEST; AGE; BREATH ANALYSIS; CHINA; COMPLICATION; DIABETES MELLITUS, TYPE 2; FOLLOW UP; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; MICROBIOLOGY; RISK FACTOR; SEX DIFFERENCE;

AGE FACTORS; AGED; BREATH TESTS; CARBON RADIOISOTOPES; CHINA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX FACTORS; UREA;

EID: 84953837562     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2677     Document Type: Article

References (33)

1. Xu Y, Wang LM, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013; 310(9): 948-958.
2. Hsieh MC, Wang SSW, Hsieh YT, Kuo FC, Soon MS, Wu DC. Helicobacter pylori infection associated with high HbA1c and type 2 diabetes. Eur J Clin Invest 2013; 43(9): 949-956.
3. Ozen A, Furman A, Berber M, et al. The effect of helicobacter pylori and economic status on growth parameters and leptin, ghrelin, and insulin-like growth factor (IGF)-I concentrations in children. Helicobacter 2011; 16(1): 55-65.
4. Xie C, Lu NH. Review: clinical management of helicobacter pylori infection in china. Helicobacter 2015; 20(1): 1-10.
5. Georges JL, Rupprecht HJ, Blankenberg S, et al. Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol 2003; 92(5): 515-521.
6. Simanek AM, Dowd JB, Aiello AE. Persistent pathogens linking socioeconomic position and cardiovascular disease in the US. Int J Epidemiol 2009; 38(3): 775-787.
7. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115(5): 1111-1119.
8. Chen Y, Blaser MJ. Association between gastric Helicobacter pylori colonization and glycated hemoglobin levels. J Infect Dis 2012; 205(8): 1195-1202.
9. Jeon CY, Haan MN, Cheng C, et al. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care 2012; 35(3): 520-525.
10. Ko GTC, Chan FKL, Chan WB, et al. Helicobacter pylori infection in Chinese subjects with type 2 diabetes. Endocr Res 2001; 27(1-2): 171-177.
11. Xia HHX, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: Implications in gastric carcinogenesis. Am J Gastroenterol 2001; 96(1): 16-26.
12. Wang F, Zhu J, Yao P, et al. Cohort profile: the Dongfeng-Tongji cohort study of retired workers. Int J Epidemiol 2013; 42(3): 731-740.
13. 14carbon urea breath test for diagnosis of H pylori in dyspeptic patients. World J Gastroenterol 2007; 13(6): 925-929.
14. Assoc AD. Standards of medical care in diabetes-2010. Diabetes Care 2010; 33: S11-S61.
15. So WY, Tong PC, Ko GT, et al. Low plasma adiponectin level, white blood cell count and Helicobacter pylori titre independently predict abnormal pancreatic beta-cell function. Diabetes Res Clin Pract 2009; 86(2): 89-95.
16. Tseng CH. Diabetes, insulin use and Helicobacter pylori eradication: a retrospective cohort study. BMC Gastroenterol 2012; 12: 46.
17. Lutsey PL, Pankow JS, Bertoni AG, Szklo M, Folsom AR. Serological evidence of infections and type 2 diabetes: the multiethnic study of atherosclerosis. Diabetic Med 2009; 26(2): 149-152.
18. Buell C, Kermah D, Davidson MB. Utility of A1C for diabetes screening in the 1999-2004 NHANES population. Diabetes Care 2007; 30(9): 2233-2235.
19. Herman WH, Engelgau MM, Zhang Y, Brown MB. Use of GHb (HbA1c) to screen for undiagnosed diabetes in the US population. Diabetes Care 2000; 23(8): 1207-1208.
20. Rohlfing CL, Little RR, Wiedmeyer HM, England JD, Goldstein DE. Use of GHb (HbA(1c)) to screen for undiagnosed diabetes in the US population - Response. Diabetes Care 2000; 23(8): 1208-1208.
21. Diomedi M, Stanzione P, Sallustio F, et al. Cytotoxin-associated Gene-A-positive Helicobacter pylori strains infection increases the risk of recurrent atherosclerotic stroke. Helicobacter 2008; 13(6): 525-531.
22. Hamed SA, Amine NF, Galal GM, et al. Vascular risks and complications in diabetes mellitus: the role of helicobacter pylori infection. J Stroke Cerebrovasc Dis 2008; 17(2): 86-94.
23. Manco M, Putignani L, Bottazzo GF. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 2010; 31(6): 817-844.
24. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. Brit Med J 1998; 316(7138): 1130-1132.
25. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Brit Med J 2000; 321(7255): 199-204.
26. Ridker PM, Danesh J, Youngman L, et al. A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar US men. Ann Intern Med 2001; 135(3): 184-188.
27. Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, et al. Ethnic differences in C-reactive protein concentrations. Clin Chem 2008; 54(6): 1027-1037.
28. Shintani M, Ogawa Y, Ebihara K, et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001; 50(2): 227-232.
29. Williams J, Mobarhan S. A critical interaction: leptin and ghrelin. Nutr Rev 2003; 61(11): 391-393.
30. Francois F, Roper J, Joseph N, et al. The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin. BMC Gastroenterol 2011; 11: 46.
31. Gunji T, Matsuhashi N, Sato H, et al. Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am J Gastroenterol 2008; 103(12): 3005-3010.
32. Isomoto H, Ueno H, Nishi Y, Wen CY, Nakazato M, Kohno S. Impact of Helicobacter pylori infection on ghrelin and various neuroendocrine hormones in plasma. World J Gastroenterol 2005; 11(11): 1644-1648.
33. Nwokolo CU, Freshwater DA, O'Hare P, Randeva HS. Plasma ghrelin following cure of Helicobacter pylori. Gut 2003; 52(5): 637-640.